» Authors » D Wiles

D Wiles

Explore the profile of D Wiles including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 207
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Spiller H, Wiles D, Russell J, Casavant M
Hum Exp Toxicol . 2015 Apr; 35(2):109-13. PMID: 25825412
Background: Tiagabine is a novel antiepileptic that acts by increasing synaptic and extracellular gamma-aminobutyric acid concentrations. Information concerning overdose of tiagabine is limited. After introduction, an increasing number of off-label...
2.
Wiles D, Tzeng J, Russell J, Casavant M
Neth J Med . 2014 Sep; 72(7):383-4. PMID: 25178776
No abstract available.
3.
Baxter G, Graham A, Lawrence J, Wiles D, Paterson J
Eur J Nutr . 2002 Mar; 40(6):289-92. PMID: 11876493
Background: Salicylic acid is a chemical signal in plants infected by pathogens and it is responsible for the anti-inflammatory action of aspirin. Patients who take aspirin have a reduced risk...
4.
Baxter G, Lawrence J, Graham A, Wiles D, Paterson J
Ann Clin Biochem . 2002 Feb; 39(Pt 1):50-5. PMID: 11853189
Background: Salicylic acid (SA) is present in the serum of people who have not taken salicylate drugs. Now we have examined the urine of these subjects and found that it...
5.
Blacklock C, Lawrence J, Wiles D, Malcolm E, Gibson I, Kelly C, et al.
J Clin Pathol . 2001 Jun; 54(7):553-5. PMID: 11429429
Aims: To determine serum salicylic acid concentrations in non-vegetarians and vegetarians not taking salicylate drugs, and to compare these concentrations with those found in patients taking aspirin, 75 mg daily....
6.
Paterson J, Blacklock C, Campbell G, Wiles D, Lawrence J
J Clin Pathol . 1998 Nov; 51(7):502-5. PMID: 9797725
Aim: To examine sera for the presence of salicylic acid and 2,3- and 2,5-dihydroxybenzoic acids (2,3- and 2,5-DHBA), in individuals not taking salicylate drugs. Methods: Extracts of acidified serum samples...
7.
McCreadie R, Macdonald E, Blacklock C, Wiles D, Halliday J, Paterson J
BMJ . 1998 Sep; 317(7161):784-5. PMID: 9740565
No abstract available.
8.
McCreadie R, Macdonald E, Wiles D, Campbell G, Paterson J
Br J Psychiatry . 1995 Nov; 167(5):610-7. PMID: 8564316
Background: Tardive dyskinesia (TD) may be mediated through free radical damage to neurons. Plasma lipid peroxide levels are a measure of radical damage to fats. Vitamin E is a free...
9.
McCreadie R, Wiles D, Grant S, Crockett G, Mahmood Z, Livingston M, et al.
Acta Psychiatr Scand . 1989 Dec; 80(6):597-602. PMID: 2694767
Of 49 schizophrenic patients followed up 2 years after their first admission to hospital, 37% were well, 47% had been readmitted to hospital at some time over the 2 years,...
10.
Soni S, Wiles D, Schiff A, Bamrah J
Br J Psychiatry . 1988 Sep; 153:382-4. PMID: 3250675
Depot neuroleptics are now commonly used for maintenance therapy of schizophrenia. Their physicochemical composition makes them ideal for such use because they are long-acting and show stable blood levels for...